PureTech Health (PRTC) Research & Development (2024 - 2025)

PureTech Health (PRTC) reported Research & Development of -$24.9 million for Q2 2025, up 36.04% on a QoQ basis from -$38.9 million in Q4 2024.

PureTech Health (PRTC) has 2 years of Research & Development data on file, last reported at -$24.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn - 626,092.00
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn - 4.32 Mn
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn -101.30 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn - -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn - 1.46 Mn
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn 961.60 Mn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn 1.54 Bn
8 Evaxion A 65.44 Bn 65.42 Bn - -2.30 Mn
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn 364.87 Mn
10 PureTech Health 86.36 Mn -190.94 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2025 -24.90 Mn
Dec 31, 2024 -38.93 Mn